Interestingly, while NOD2 has been shown to be significantly highly expressed in CRC patients as compared to healthy controls (31), we observed a strongly increased overall survival as well as median survival time in NOD2hi patients as compared to NOD2lo patients (Figure 4A). The gene discussed is NOD2; the disease is colorectal carcinoma.